Bone UltraSonic Scanner (BUSS) Clinical Optimization Study
BUSS
Phase I Study of Portable Bone Ultrasonometer for Osteoporosis Assessment
2 other identifiers
observational
100
1 country
1
Brief Summary
The aim of this clinical study using Bone UltraSonic Scanner (BUSS) is to obtain clinical data which will help to optimize the BUSS examination procedure and its diagnostic algorithms for assessment of bone conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 24, 2010
CompletedFirst Posted
Study publicly available on registry
January 26, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedMarch 31, 2014
March 1, 2014
1 year
January 24, 2010
March 28, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To obtain clinical data which will help to optimize the BUSS examination procedure and its diagnostic algorithms for assessment of bone conditions.
6 months
Eligibility Criteria
Study participants will consist of groups with no history of osteoporosis, established osteoporosis and may include documented history of fracture.
You may qualify if:
- Any race or ethnical group DEXA examination scheduled within next two weeks or DEXA examination was completed within the last six months adn DEXA results are available
You may not qualify if:
- Open wounds or rashes on the tibial testing area Active skin infection Recent tibia surgery Abnormal tibia Anatomy Current or previous tibial fracture Body Mass Index \>34.9 Hyperparathyroidism or hypoparathyroidism within 5 years Osteitis deformans Renal osteodystrophy Osteomalacia Stroke with total or partial paralysis with residual disability lasting more than 3 months Current or recent (within past 6 months) use of bone-active drugs Drugs under research protocols Chronic use of over the counter antacids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Artann Laboratorieslead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Health Smart Medical Center
Philadelphia, Pennsylvania, 19115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Armen Sarvazyan, Ph.D., D.Sc.
Artann Laboratories
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2010
First Posted
January 26, 2010
Study Start
January 1, 2010
Primary Completion
January 1, 2011
Study Completion
January 1, 2011
Last Updated
March 31, 2014
Record last verified: 2014-03